Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Diagnostic Microbiology and Infectious Disease|April 6, 2005
Cefdinir: an oral alternative to parenteral cephemsArchana Chatterjee, Ellen S Moland, Kenneth S ThomsonJournal of Clinical Microbiology|June 29, 2007
Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratorySoo-Young Kim, Seong Geun Hong, Ellen S Moland, et al.Journal of Clinical Microbiology|July 8, 2011
KPC screening by updated BD Phoenix and Vitek 2 automated systemsKenneth S Thomson, Iraida E Robledo, Guillermo J Vázquez, et al.Antimicrobial Agents and Chemotherapy|October 27, 2004
Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in CanadaBaha Abdalhamid, Johann D D Pitout, Ellen S Moland, et al.Journal of Clinical Microbiology|June 29, 2007
Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamasesKenneth S Thomson, Nancy E Cornish, Seong G Hong, et al.Journal of Clinical Microbiology|September 7, 2006
Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002Ellen S Moland, Nancy D Hanson, Jennifer A Black, et al.Journal of Clinical Microbiology|September 8, 2005
Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremiaWonkeun Song, Ellen S Moland, Nancy D Hanson, et al.The Journal of Antimicrobial Chemotherapy|June 1, 2002
Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamasesNancy D Hanson, Ellen S Moland, Ashfaque Hossain, et al.Antimicrobial Agents and Chemotherapy|June 4, 2008
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergyEllen S Moland, David W Craft, Seong-geun Hong, et al.Pageof 1